Androgen receptor-negative prostate cancer is vulnerable to SWI/SNF-targeting degrader molecules
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 32 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 32 samples: 32 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE313838_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1381657 and SRA study SRP655396. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 32 sample titles: 32 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9376333 WCM1078 organoids, inactive compound, 24h, rep1, mRNA
- GSM9376334 WCM1078 organoids, inactive compound, 24h, rep2, mRNA
- GSM9376335 WCM1078 organoids, inactive compound, 24h, rep3, mRNA
- GSM9376336 WCM1078 organoids, inactive compound, 48h, rep1, mRNA
- GSM9376337 WCM1078 organoids, inactive compound, 48h, rep2, mRNA
- GSM9376338 WCM1078 organoids, inactive compound, 48h, rep3, mRNA
- GSM9376339 WCM1078 organoids, active compound, 24h, rep1, mRNA
- GSM9376340 WCM1078 organoids, active compound, 24h, rep2, mRNA
- GSM9376341 WCM1078 organoids, active compound, 24h, rep3, mRNA
- GSM9376342 WCM1078 organoids, active compound, 48h, rep1, mRNA
- GSM9376343 WCM1078 organoids, active compound, 48h, rep2, mRNA
- GSM9376344 WCM1078 organoids, active compound, 48h, rep3, mRNA
- GSM9376345 WCM1078 organoids, inactive compound, 4h, input, ChIP
- GSM9376346 WCM1078 organoids, inactive compound, 4h, rep1, ChIP
- GSM9376347 WCM1078 organoids, inactive compound, 4h, rep2, ChIP
- GSM9376348 WCM1078 organoids, active compound, 4h, input, ChIP
- GSM9376349 WCM1078 organoids, active compound, 4h, rep1, ChIP
- GSM9376350 WCM1078 organoids, active compound, 4h, rep2, ChIP
- GSM9376351 WCM1078 organoids, inactive compound, 4h, rep1, ATAC
- GSM9376352 WCM1078 organoids, inactive compound, 4h, rep2, ATAC
- GSM9376353 WCM1078 organoids, inactive compound, 4h, rep3, ATAC
- GSM9376354 WCM1078 organoids, active compound, 4h, rep1, ATAC
- GSM9376355 WCM1078 organoids, active compound, 4h, rep2, ATAC
- GSM9376356 WCM1078 organoids, active compound, 4h, rep3, ATAC
- GSM9376357 WCM1078 organoids, inactive compound, 72h, scRNA
- GSM9376358 WCM1078 organoids, active compound, 72h, scRNA
- GSM9376359 PCa16 organoids, inactive compound, 72h, scRNA
- GSM9376360 PCa16 organoids, active compound, 72h, scRNA
- GSM9376361 WCM1078 organoids, inactive compound, 24h, rep1, eRNA
- GSM9376362 WCM1078 organoids, inactive compound, 24h, rep2, eRNA
- GSM9376363 WCM1078 organoids, active compound, 24h, rep1, eRNA
- GSM9376364 WCM1078 organoids, active compound, 24h, rep2, eRNA
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE274731 A Molecular Switch from Tumor Suppressor to Oncogene in ER-Positive Breast Cancer: Role of Androgen Receptor, JAK-STAT, and Lineage Plasticity 102 samples shares swi, androgen
- GSE274717 A Molecular Switch from Tumor Suppressor to Oncogene in ER-Positive Breast Cancer: Role of Androgen Receptor, JAK-STAT, and Lineage Plasticity [ChIP-seq] 40 samples shares swi, androgen
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.